Randomized, Double-blind, Placebo-controlled, Multi-center Study Designed to Evaluate the Efficacy, Safety and Tolerability of Metadoxine Extended Release in Adults With Attention Deficit Hyperactive Disorder.
Phase of Trial: Phase II
Latest Information Update: 06 Aug 2013
At a glance
- Drugs Metadoxine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Sponsors Alcobra
- 06 Aug 2013 A secondary analysis of this trial was published in Postgraduate Medicine Journal, according to an Alcobra media release.
- 17 Oct 2012 Results presented at the 25th Annual Congress of the European College of Neuropsychopharmacology.
- 17 Apr 2012 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History